TaqMan™ Liquid Biopsy dPCR Assay (Applied Biosystems™)

TaqMan Liquid Biopsy digital PCR assays combine the TaqMan fluorogenic 5’ nuclease chemistry with digital PCR methodology to provide a sensitive, wet-lab validated solution for accurate detection of low-frequency mutant alleles in cancer research.

TaqMan Liquid Biopsy dPCR Assays have been optimized to work with digital PCR and droplet digital PCR systems to achieve the high performance required to detect and quantify mutations present at very low frequencies and have been wet-lab tested and are guaranteed to perform on the Applied Biosystems QuantStudio 3D and Bio-Rad QX-100 and QX-200 systems.

Overview of sensitive mutation detection using TaqMan Liquid Biopsy dPCR Assays:
• Optimized digital PCR performance—wet lab–verified TaqMan assays targeting over 100 common cancer mutations
• High sensitivity—detect and quantify rare mutant prevalence to ≤0.1%
• Cost-effective and convenient—single-tube format includes both wild type and mutant alleles
• Streamlined analysis—advanced algorithms for better quantification of rare mutations
• Guaranteed performance—assay replaced or account credited if you are not satisfiedif it doesn’t perform in accordance with our guarantee
• Custom design support—guidance available for Custom TaqMan SNP Genotyping Assays on the QuantStudio 3D Digital PCR System that are not part of this wet lab–verified collection.

All of our predesigned TaqMan Assays are covered by the TaqMan Assays qPCR Guarantee.*

*Subject to terms and conditionsTerms and conditions apply. For complete details, go to www.thermofisher.com/taqmanguarantee.